Solnerstotug

N/A

Report date: 2025/05/22 17:22:42

Base Information

Drug NameSolnerstotug

Drug Alias NameSNS-VISTASNS-101

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionT lymphocytes stimulantsV-domain Ig suppressor of T-cell activation inhibitorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects

TargetsV-domain Ig suppressor of T-cell activation

Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisUrinary Bladder Neoplasms +[20]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesSensei Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesSensei Biotherapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursNeoplasm MetastasisUrinary Bladder Neoplasms +[19]

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A